Pédiatrie [Pediatrics].

Details

Ressource 1Request a copy Sous embargo indéterminé.
State: Public
Version: Final published version
Serval ID
serval:BIB_09C64A04EE59
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Pédiatrie [Pediatrics].
Journal
Revue Médicale Suisse
Author(s)
Fischer C.J., Giannoni E., Truttmann A.C., Tolsa J.F., Chevallay M., El Ezzi O., Seneggen E., Hohlfeld J., de Buys Roessingh A., Pauchard J.Y., Gehri M., Hauschild M.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
2012
Peer-reviewed
Oui
Volume
8
Number
323
Pages
51-56
Language
french
Notes
Publication types: English Abstract ; Journal ArticlePublication Status: ppublish
Abstract
Several preliminary studies suggest that prophylactic administration of probiotics reduces the incidence of necrotizing enterocolitis (NEC) in preterm infants, and several neonatology units have introduced this treatment under strict surveillance. Nonetheless, breast milk feeding remains the mainstay of NEC prevention. The beta-blocker propranolol, known for its effectiveness on cutaneous hemangiomas, is also proving useful for the treatment of subglottic or visceral hemangiomas. Following the decrease in severe bacterial infections thanks to widespread vaccinations, the McCarthy clinical score has regained importance in the prediction of the risk of bacterial infection in febrile infants. It is easy to use, economical, and has a diagnostic value comparable to laboratory tests. The new WHO growth charts have been introduced in Switzerland in 2011 to take into account the increasing regional and ethnic variations in our country. Any significant change in growth velocity should prompt an evaluation of the need of further investigations.
Keywords
Adrenergic beta-Agonists/therapeutic use, Bacterial Infections/complications, Bacterial Infections/diagnosis, Breast Feeding, Enterocolitis, Necrotizing/prevention & control, Fever/microbiology, Growth Charts, Hemangioma/drug therapy, Humans, Infant, Infant, Newborn, Infant, Premature, Diseases/prevention & control, Laryngeal Neoplasms/drug therapy, Mediastinal Neoplasms/drug therapy, Neoplasms/drug therapy, Pediatrics/trends, Probiotics/therapeutic use, Propranolol/therapeutic use, Risk Factors, Skin Neoplasms/drug therapy, Switzerland, Treatment Outcome, World Health Organization
Pubmed
Create date
06/06/2012 19:19
Last modification date
20/08/2019 13:31
Usage data